This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
. “In this era of tremendous uncertainty, it is crucial that policymakers use every tool in their toolkit to promote public health and safety. You can read and download the memo to share with your local policymakers here.
Patients are looking to their medical providers for information on cannabis safety, potential for interactions with pharmaceuticals, and therapeutic applications. This position cripples the ability of clinicians to advise patients or to influence the burgeoning cannabis industry. Download at [link].
NORML is pleased to announce that its newly updated and revised publication, Clinical Applications for Cannabis & Cannabinoids: A Review of the Recent Scientific Literature, 2000 — 2021 , is now available for download on the Kindle app. Proceeds from the purchase of the new book directly fund NORML’s cannabis advocacy efforts.
Download PDF. The Arkansas Attorney General (“AG”) issued an August 2nd Opinion addressing the scope of the safe harbor for employers provided by the Arkansas Medical Marijuana Amendment (“Amendment”) for “safety sensitive position.” Representative Wing asks whether the phrase “safety sensitive position” includes: a position.
As Florida’s fastest growing network of medical marijuana physicians, CannaMD is committed to making sure patients have access to affordable cannabis care. That’s why we’re proud to offer patients up to $75 off a year with our referral program ! This Cyber Monday, patients can enjoy 10% off online orders!
Medical marijuana research, advocacy, and acceptance is on the rise – and that means more and more great news for Florida medical marijuana patients. As Pryor wrote in a memo: Prosecuting these cases has no public safety value and is a costly and counterproductive use of limited resources. We couldn’t agree more!
If you’re a Florida medical marijuana patient, chances are you’ve heard of House Bill 1455 – a proposed bill making its rounds through the state legislature as we speak. But, behind the outrage, lies a larger conversation regarding free speech, fair pricing, and the sanctity of the physician-patient relationship.
Patients are looking to their medical providers for information on cannabis safety, potential for interactions with pharmaceuticals, and therapeutic applications. This position cripples the ability of clinicians to advise patients or to influence the burgeoning cannabis industry. Download at [link].
This deceptive marketing of unproven treatments raises significant public health concerns because patients and other consumers may use them instead of approved therapies to treat serious and even fatal diseases. Of the 22 patients, 19 experienced adverse events after ingesting delta-8 THC-containing food products (e.g.,
Despite the companies’ submitting the required data demonstrating the “reasonable expectation of safety under the recommended conditions of use,” the FDA rejected the applications, citing the drug preclusion clause. Available at: www.fda.gov/media/131878/download. US Food and Drug Administration website. Accessed October 17, 2022.
Each year, Americans for Safe Access (ASA) analyzes, summarizes, and critiques legislation and regulations as they become law and develops this report to assess how these programs are serving the needs of patients. PATIENT RIGHTS AND CIVIL PROTECTIONS FROM DISCRIMINATION …… 16. CONSUMER SAFETY AND PROVIDER REQUIREMENTS.
With a growing recognition of its potential therapeutic benefits, Iowa has established a medical marijuana program to provide eligible patients with access to cannabis-based treatments. The Iowa medical marijuana program represents a significant step forward in providing patients with alternative treatment options.
After the 4-week trial, continue THC:CBD spray if the person has had at least a 20% reduction in spasticity-related symptoms on a 0 to 10 patient-reported numeric rating scale. how communication will be managed between the initiating specialist prescriber, the other prescriber, the patient, family and/or carers. Tools and resources.
If stopped with a cannabis product in their car, medical marijuana patients must be able to produce a valid medical marijuana card. Florida law requires that patients keep the medical marijuana in the original packaging, as well as have the dispensary insert with product information and the recommended dosage.
To become an Oklahoma medical marijuana patient, you can first talk with one of our doctors to see if you qualify and we will help you through the application process. A physician may certify a patient if they feel that the use of medical marijuana will be an appropriate treatment for that patient’s particular medical condition.
For years, my patients have found that products containing some THCA along with THC are the most effective for pain and other symptoms – so what exactly is THCA doing to help? I typically recommend my patients use a small piece of cannabis flower, about the size of a pea, and steep in just boiled water for 5 minutes.
This is particularly important in the United States with respect to the FDA, which has bemoaned a lack of data it can use to create policy and regulations of cannabis products, and in Europe with respect to the Food Safety Division of the European Commission’s application of the Novel Foods designation to cannabidiol (CBD). September 2017.
Are you able to answer your patients’ medical marijuana questions? We also provide free downloadable resources: ‘The Endocannabinoid System and Medical Marijuana in 15 minutes!’ and ‘The Perioperative Considerations for the Patient Utilizing Cannabinoid-based Medicines and Products.’ Unfortunately, this did not occur.
However, the nature of the government regulations and the subsequent complexity of prescribing, as well as doctors’ safety uncertainties and the stigma of the plant, remain contributing barriers to patient access. The review, however, did not cover patient access to medicinal cannabis. The states’ situation varies substantially.
As a result, major testing labs are not properly detecting these common pathogens, exposing patients and cannabis employees to undue health concerns. Cannabis is ground up and inhaled, often by immunocompromised patients. For public safety, it is imperative labs have transparent methods and preferably peer-reviewed.
“It’s very important from our perspective to ensure that the Australian patient gets medicine first. The first medicinal cannabis ‘mother’ plants are expected to be imported from Israel within a month, with manufacturing scheduled to begin within the first half of this year, to supply 5,000 Australian patients.
Even those of our community who have been advocates or entrepreneurs in the cannabis space for decades often find themselves digging into some point of the new laws that may have seemed insignificant to the authors but has profound consequences for thousands of patients and livelihoods. Does anybody here have a county-issued medical card?
The study involved 100 treatment-resistant patients and were randomized to psilocybin or the nicotine patch, each receiving the same cognitive-behavioral therapy. At 12 months, 59% of the patients who received the psilocybin treatment remained abstinent, while only 28% of those who received the nicotine patch remained abstinent.
In a 2015 statement, the Canadian Pediatric Society said that “there is little data to support either the efficacy or safety of cannabis use for any indications in children.”. In Ontario, doctors have been advised not to prescribe marijuana to patients under 25, unless other options have failed. Best high CBD strain for autism.
Hickman told the doctor he was a medical marijuana patient who uses the medicine to treat PTSD. However, the bills do include stipulations for jobs that are more safety sensitive, where marijuana use could pose a safety risk to the individual or someone else. DO YOU QUALIFY FOR MEDICAL MARIJUANA?
Knowing Your Rights , provided by the national medical cannabis advocacy organization Americans for Safe Access, admonishes current cannabis consumers: Medical cannabis patients and their providers are vulnerable to federal and state raids, arrest, prosecution, and incarceration. You step out of the car, and walk toward the entrance.
Sam’s large social media outlets and podcast (over 1 million downloads per episode) frequently discuss psychedelics, which has opened the conversation to millions of new listeners and readers. Peter’s podcast has tens of millions of downloads, with many episodes discussing psychedelics and mental health. Sam Harris. Brian Muraresku.
The Medics prescribe the patient’s recommendation for medical cannabis products that can be purchased by the patient (1) in various delivery routes : oral, inhalation, tinctures, oils, topicals, smokable; and (2) in various products and strains, depending on the particular dispensary. Almut Winterstein, Ph.D.,
We organize all of the trending information in your field so you don't have to. Join 14,000+ users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content